Pfizer COVID pill showed no benefit in younger adults but helped older persons-study

Study: Pfizer COVID pill showed no benefit in younger adults WASHINGTON (AP) — Pfizer's COVID-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of hospitalization and death for high-risk seniors, according to a large study published Wednesday. AP NEWS

...

The researchers found that Paxlovid reduced hospitalizations among people 65 and older by roughly 75% when given shortly after infection. That’s consistent with earlier results used to authorize the drug in the U.S. and other nations.

But people between the ages of 40 and 65 saw no measurable benefit, according to the analysis of medical records. ...